Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
PLOS Global Public Health|December 5, 2024
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA studyNigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, et al.
Nature Communications|March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig A Magaret, Li Li, Allan C deCamp, et al.
Lancet (London, England)|July 27, 2018
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H Barouch, Frank L Tomaka, Frank Wegmann, et al.
Medrxiv : the Preprint Server for Health Sciences|December 4, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Jinal N Bhiman, Yashica Ganga, et al.
PLOS Global Public Health|April 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Jinal N Bhiman, Yashica Ganga, et al.
The New England Journal of Medicine|March 24, 2021
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in AdultsGlenda E Gray, Linda-Gail Bekker, Fatima Laher, et al.
Nature Communications|June 13, 2023
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infectionSunil K Ahuja, Muthu Saravanan Manoharan, Grace C Lee, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Eclinicalmedicine|February 4, 2025
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studyNigel Garrett, Asa Tapley, Aaron Hudson, et al.
Nature Communications|October 6, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIVNonhlanhla N Mkhize, Bo Zhang, Caroline Brackett, et al.
Pageof 17